CytRx to Present at BIO CEO & Investor Conference

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical company specializing in oncology, today announced that President and Chief Executive Officer Steven A. Kriegsman and Vice President of Business Development David Haen will provide a business update at the 14th Annual BIO CEO & Investor Conference on Tuesday, February 14, at 11:30 a.m. Eastern time (8:30 a.m. Pacific Time). The conference will be held at the Waldorf=Astoria hotel in New York City. “We are looki

Feed Date: 
February 6, 2012